Lilly’s oncology pipeline gets fresh boost with AurKa buyout
In a deal aimed at expanding its oncology portfolio further, Eli Lilly and Company (LLY) will acquire cancer drug maker AurKa Pharma. The decision comes…
In a deal aimed at expanding its oncology portfolio further, Eli Lilly and Company (LLY) will acquire cancer drug maker AurKa Pharma. The decision comes…
As Facebook’s (FB) shares inched 0.4% up in pre-market trading on Monday, the embattled social media giant revealed it has already suspended about 200 apps…
At a time when business ties between the US and China are on the threshold of a major shift, investment bank JPMorgan Chase (JPM) is…
Xerox (XRX) abandoned its proposed $6.1 billion deal with Fujifilm and agreed to hand over the company’s leadership to a new management team. These decisions…
It is very difficult to judge the thinking of President Donald Trump. While both China and the US were bracing for an impact from a…
US stocks are set to open higher after ending mixed on Friday, as investors are hoping that the trade tensions would dissolve following the US-China…
Snapchat (SNAP) users heaved a sigh of relief as the much-awaited app redesign was rolled out to iOS users last week, the second in the…
Pfizer (PFE) is an interesting stock to follow. Apart from being a great dividend stock, the company also boasts of a diversified portfolio, strong free…
After inviting criticism from various quarters for having two customers arrested in mid-April allegedly on racial grounds, Starbucks Corp. (SBUX) is shifting into damage control…
Cisco Systems (CSCO) decided to remove all its online advertisements from YouTube over fears of brand tarnishment in case of the ads appearing on graphic…